WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018081508) MEMANTINE COMBINATIONS AND USE
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/081508    International Application No.:    PCT/US2017/058677
Publication Date: 03.05.2018 International Filing Date: 27.10.2017
IPC:
A61K 31/47 (2006.01), A61K 45/06 (2006.01), C07C 13/615 (2006.01)
Applicants: CHASE PHARMACEUTICAL CORPORATION [US/US]; 400 Interpace Parkway Parsippany, New Jersey 07054 (US)
Inventors: CLARENCE-SMITH, Kathleen E.; (US).
CHASE, Thomas N.; (US)
Agent: TOWNSLEY, Alan C.; Sughrue Mion, PLLC 2100 Pennsylvania Ave., N.W., Suite 800 Washington, District of Columbia 20037-3213 (US).
PHAN-KERR, TU A.; SUGHRUE MION, PLLC 2100 Pennsylvania Ave., N.W., Suite 800 Washington, District of Columbia 20037-3213 (US)
Priority Data:
62/414,359 28.10.2016 US
62/424,085 18.11.2016 US
62/423,999 18.11.2016 US
Title (EN) MEMANTINE COMBINATIONS AND USE
(FR) COMBINAISONS ET UTILISATION DE MÉMANTINE
Abstract: front page image
(EN)A pharmaceutical combination of memantine and a non-anticholinergic antiemetic agent for the treatment of hypocholinergic disorders in further combination with high doses of donepezil and with solifenacin, and kits comprising said combination. A pharmaceutical combination of memantine and solifenacin for the treatment of hypocholinergic disorders, including Alzheimer type dementia, in further combination with high doses of donepezil, and kits comprising said combination.
(FR)L'invention concerne une combinaison pharmaceutique de mémantine et d'un agent antiémétique non anticholinergique pour le traitement de troubles hypocholinergiques combinée en outre avec des doses élevées de donépézil et de solifénacine, et des kits comprenant ladite combinaison. L'invention concerne une combinaison pharmaceutique de mémantine et de solifénacine pour le traitement de troubles hypocholinergiques, notamment de la démence de type Alzheimer, combinée en outre avec des doses élevées de donépézil, et des kits comprenant ladite combinaison.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)